National Lab Briefs

Detecting Interest In The SSC Scientists at Oak Ridge (Tenn.) National Laboratory are determined to play a role in the $7 billion Superconducting Supercollider project through a joint collaboration with MIT scientists on the supercollider's huge detectors. The 54-mile-long, proton-proton accelerator being built in Texas is scheduled to contain four $400 million detectors, each weighing 40,000 tons and standing 50 feet high, 50 feet wide, and 150 feet long. Hundreds of high-energy physicists fro

| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

Detecting Interest In The SSC Scientists at Oak Ridge (Tenn.) National Laboratory are determined to play a role in the $7 billion Superconducting Supercollider project through a joint collaboration with MIT scientists on the supercollider's huge detectors. The 54-mile-long, proton-proton accelerator being built in Texas is scheduled to contain four $400 million detectors, each weighing 40,000 tons and standing 50 feet high, 50 feet wide, and 150 feet long. Hundreds of high-energy physicists from dozens of institutions around the world will be involved in shaping the detectors to match the various experiments planned for the SSC, and Oak Ridge wants to be in the forefront of such efforts. Officials say that the lab has the space available and the technical know-how from both its long history of nuclear physics and its current work in heavy ion research. It also has as its director Alvin Trivelpiece, who was the leading advocate ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies